University Hospital Münster

Futó vizsgálatok

• Még nem toboroz

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  Within-Session Repeatability of EUS-Guided Portal Pressure Gradient Measurement

  NCT07877298· University Hospital Muenster· Forrás

• Toboroz

  Endohepatology-Based Reclassification of Treatment Indication in High-Risk MASLD

  NCT07877272· University Hospital Muenster· Forrás

• Még nem toboroz

  Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair

  NCT07380932· Atrial Fibrillation Network· Forrás

• Toboroz

  Registry for Duchenne and Becker Muscular Dystrophy

  NCT07402122· Dr. Andreas Ziegler· Forrás

• Toboroz

  Biomechanical Effects of EMST® on Swallowing Function in Parkinson's Disease

  NCT07606547· University Hospital Muenster· Forrás

• Toboroz

  ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer

  NCT06801899· Insel Gruppe AG, University Hospital Bern· Forrás

• Toboroz

  A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  NCT07101328· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  NCT07599813· 2. fázis· Apollo Therapeutics Ltd· Forrás

• Toboroz

  Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

  NCT07585890· University Medical Center Groningen· Forrás

• Toboroz

  Mental Health and Suicidality in Glioblastoma Patients in Germany

  NCT07409584· University Hospital, Essen· Forrás

• Toboroz

  Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices

  NCT07273903· Heinrich-Heine University, Duesseldorf· Forrás

• Toboroz

  Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

  NCT07314164· Ipsen· Forrás

• Toboroz

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia

  2025-520982-39-00· 3. fázis· Universita Degli Studi Di Milano Bicocca· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™

  NCT07668687· Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd· Forrás

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· 3. fázis· Amgen· Forrás

• Toboroz

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  NCT06782490· 2. fázis· Celgene· Forrás

• Fut, nem toboroz

  A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy

  NCT06821542· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  Video-Tumorboard PLUS

  NCT06980740· University Hospital Muenster· Forrás

• Toboroz

  Multicenter Trial on Surgical Outcome and Quality of Life in Juxta-medullary Tumors

  NCT07056023· University Hospital Muenster· Forrás

• Toboroz

  Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment

  NCT06696183· 2. fázis· Technische Universität Dresden· Forrás

• Fut, nem toboroz

  Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis

  NCT06507865· W.L.Gore & Associates· Forrás

• Toboroz

  A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

  NCT06585774· 3. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

  NCT06516965· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)

  NCT06780150· Hoffmann-La Roche· Forrás

• Toboroz

  Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease

  NCT06523608· University Hospital Muenster· Forrás

• Toboroz

  Semibranch Registry - Retrospective

  NCT06374355· University Hospital Muenster· Forrás

• Toboroz

  Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation

  NCT07777744· University Hospital, Basel, Switzerland· Forrás

• Toboroz

  Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer

  NCT06122584· 3. fázis· ABX advanced biochemical compounds GmbH· Forrás

• Toboroz

  CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

  2023-503317-29-00· 3. fázis· Institut Gustave Roussy· Forrás

• Toboroz

  Phase 3 Clinical Trial With Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

  NCT05944016· 3. fázis· University Hospital Goettingen· Forrás

• Toboroz

  Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

  NCT05056220· 3. fázis· Aleksander Krag· Forrás

• Toboroz

  Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

  NCT06279793· 2. fázis· GCP-Service International West GmbH· Forrás

• Toboroz

  Correlation of Cardiac Output Determined by Echocardiography and Indirect Calorimetry in Critically Ill Patients in Cardiogenic Shock on Extracorporeal Circulatory Life Support

  NCT06369818· Universität Münster· Forrás

• Toboroz

  Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.

  NCT06059053· University Hospital Muenster· Forrás

• Fut, nem toboroz

  Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments

  NCT07239804· Evangelical Hospital Düsseldorf· Forrás

• Toboroz

  Intensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: a randomized controlled trial - METAPANC

  2023-503558-10-00· 3. fázis· Universitaetsmedizin Goettingen· Forrás

• Fut, nem toboroz

  German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa

  NCT06095713· Universität Münster· Forrás

• Fut, nem toboroz

  Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

  NCT06088290· 3. fázis· PharmaMar· Forrás

• Toboroz

  A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

  NCT04808505· 3. fázis· Amicus Therapeutics· Forrás

• Fut, nem toboroz

  Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System

  NCT05501873· Boston Scientific Corporation· Forrás

• Meghívásos bevonás

  A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT05735483· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment

  NCT07674173· Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd· Forrás

• Toboroz

  Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

  NCT06311708· Tenaya Therapeutics· Forrás

• Fut, nem toboroz

  Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

  NCT05555732· 3. fázis· Daiichi Sankyo· Forrás

• Meghívásos bevonás

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  NCT05667493· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás

Showing 50 of 96.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok6 toboroz
• Aortic aneurysm4 toboroz
• Liver cirrhosis4 toboroz
• Glioblasztóma3 toboroz
• Parkinson-kór3 toboroz
• Pitvarfibrilláció3 toboroz
• Szívelégtelenség3 toboroz
• Akut limfoid leukémia (ALL)2 toboroz
• Akut mieloid leukémia (AML)2 toboroz
• Amiloidózis2 toboroz
• Bronchiectasis2 toboroz
• Hasnyálmirigyrák2 toboroz
• Magas vérnyomás2 toboroz
• Máj- és epeúti rák2 toboroz
• Prosztatarák2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Depresszió1 toboroz
• Duchenne-izomdisztrófia1 toboroz
• Dystonia1 toboroz
• Essential tremor1 toboroz
• Follikuláris limfóma1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Hólyagrák1 toboroz
• Köpenysejtes limfóma1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus vesebetegség1 toboroz
• Melanóma1 toboroz
• Meningioma1 toboroz
• Multiple system atrophy1 toboroz
• Neuroblasztóma1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pompe-betegség1 toboroz
• Rheumatoid arthritis1 toboroz
• Stroke (szélütés)1 toboroz
• Tüdőrák1 toboroz
• Ventricular tachycardia1 toboroz
• Vesedaganat1 toboroz
• Zsírmáj (MASLD/MASH)1 toboroz

Lezárt vizsgálatok

• Lezárult

  Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient Measurement

  NCT07703540· University Hospital Muenster· Forrás

• Lezárult

  Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

  NCT06855056· European Foundation for Study of Chronic Liver Failure· Forrás

• Lezárult

  Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

  NCT06665724· 1. fázis· Universität Münster· Forrás

• Lezárult

  Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease

  NCT06161766· University Hospital Freiburg· Forrás

• Lezárult

  Implementing Spiritual Care in Inpatient Palliative Care

  NCT06206551· University Hospital Muenster· Forrás

• Lezárult

  Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)

  NCT07506642· University Hospital Muenster· Forrás

• Lezárult

  A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide

  NCT05901649· Janssen-Cilag Ltd.· Forrás

• Lezárult

  To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

  NCT05911009· 2. fázis· Berlin Cures GmbH· Forrás

• Lezárult

  Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).

  NCT06125808· 2. fázis· Arctic Bioscience· Forrás

• Lezárult

  Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

  NCT05499832· 3. fázis· Insel Gruppe AG, University Hospital Bern· Forrás

• Lezárult

  Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

  NCT05723848· Heinrich-Heine University, Duesseldorf· Forrás

• Lezárult

  BOLT Lithotripsy RESTORE ATK Trial

  NCT05662787· Bolt Medical· Forrás

• Lezárult

  Assessing EUS and Percutaneous Untargeted Liver Biopsy Quality

  NCT07701031· University Hospital Muenster· Forrás

• Lezárult

  A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

  NCT05651711· 3. fázis· Amgen· Forrás

• Lezárult

  A Phase 3 Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus

  NCT05306574· 3. fázis· Remegen Co. Ltd.· Forrás

• Lezárult

  A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05601882· 3. fázis· AbbVie· Forrás

• Leállították

  A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)

  NCT05568225· 2. fázis· Forma Therapeutics, Inc.· Forrás

• Lezárult

  Effects of Aerobic Exercise During the Early Rehabilitation After Ischemic Stroke

  NCT05690165· University Hospital Muenster· Forrás

• Lezárult

  Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

  NCT05458856· 3. fázis· Ipsen· Forrás

• Lezárult

  A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

  NCT05357989· 3. fázis· Annovis Bio Inc.· Forrás

• Leállították

  A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

  NCT05282121· 2. fázis· Boehringer Ingelheim· Forrás

• Leállították

  A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

  NCT05161481· 2. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

  NCT04916613· 3. fázis· UNICANCER· Forrás

• Leállították

  A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

  NCT04963270· 3. fázis· Hoffmann-La Roche· Forrás

• Leállították

  directSTIM™ Deep Brain Stimulation System Post-Market Clinical Follow-up Study on Essential Tremor

  NCT05795218· Aleva Neurotherapeutics SA· Forrás

• Toboroz

  RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

  NCT04796350· AgNovos Healthcare, LLC· Forrás

• Lezárult

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation

  NCT04698876· University Hospital Muenster· Forrás

• Lezárult

  Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")

  NCT04474678· Medical University of Vienna· Forrás

• Lezárult

  Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet

  NCT04191616· 2. fázis· Amgen· Forrás

• Leállították

  A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

  NCT04338269· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Physical Training in Glioblastoma Patients During Cytotoxic Therapy

  NCT05015543· University Hospital Muenster· Forrás

• Lezárult

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· 3. fázis· Eli Lilly and Company· Forrás

• Leállították

  A Study in Patients with a Descending TAA or PAU Treated with the E-nya Thoracic Stent Graft System

  NCT04381507· JOTEC GmbH· Forrás

• Lezárult

  Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients

  NCT04227522· 3. fázis· North Eastern German Society of Gynaecological Oncology· Forrás

• Lezárult

  CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

  NCT04136171· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

  NCT04210115· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)

  NCT04382898· 1/2. fázis· BioNTech SE· Forrás

• Lezárult

  A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

  NCT04138277· 3. fázis· Amicus Therapeutics· Forrás

• Lezárult

  A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

  NCT03900598· 1. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

  NCT03598270· 3. fázis· Grupo Español de Investigación en Cáncer de Ovario· Forrás

• Lezárult

  Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

  NCT03353831· 3. fázis· AGO Research GmbH· Forrás

• Lezárult

  Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML

  NCT03250338· 3. fázis· Arog Pharmaceuticals, Inc.· Forrás

• Lezárult

  Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer

  NCT03511664· 3. fázis· Endocyte· Forrás

• Lezárult

  Ibrutinib and Standard Immuno-Chemotherapy in Younger, High-Risk Patients With Diffuse Large B-Cell Lymphoma

  NCT03399513· 2. fázis· University Hospital Muenster· Forrás

• Lezárult

  A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

  NCT03047395· 3. fázis· AbbVie· Forrás

• Lezárult

  Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML

  NCT02461537· 3. fázis· DKMS gemeinnützige GmbH· Forrás

• Lezárult

  A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients

  NCT02017717· 3. fázis· Bristol-Myers Squibb· Forrás

• Lezárult

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· 3. fázis· The Lymphoma Academic Research Organisation· Forrás

• Lezárult

  Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

  NCT01827553· 3. fázis· University of Erlangen-Nürnberg Medical School· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Sclerosis multiplex (SM)55 munka · 2 vizsgálat
• Atópiás dermatitisz (ekcéma)34 munka · 5 vizsgálat
• Szarkóma26 munka · 2 vizsgálat
• Diffúz nagy B-sejtes limfóma (DLBCL)16 munka · 1 vizsgálat
• Endometriózis14 munka · 0 vizsgálat
• Liver cirrhosis14 munka · 11 vizsgálat
• Myasthenia gravis13 munka · 2 vizsgálat
• Méhtestrák13 munka · 0 vizsgálat
• Hodgkin-limfóma13 munka · 1 vizsgálat
• Amiloidózis12 munka · 3 vizsgálat
• Vitiligo10 munka · 0 vizsgálat
• Ventricular tachycardia8 munka · 1 vizsgálat
• Dilated cardiomyopathy8 munka · 0 vizsgálat
• Down syndrome7 munka · 0 vizsgálat
• Fabry-betegség6 munka · 1 vizsgálat
• Alopecia areata6 munka · 0 vizsgálat
• Dermatomyositis and polymyositis (myositis)4 munka · 0 vizsgálat
• Primer biliáris cholangitis (PBC)4 munka · 0 vizsgálat